Germany approves trials of COVID-19 vaccine candidate
Germany approves trials of COVID-19 vaccine candidate
April 23, 2020
Germany has given the green light for human trials of potential coronavirus vaccines developed by German biotech company BioNTech, which is racing teams in Germany, the U.S. and China to develop an agent that will stop the pandemic.
Post A Comment:
0 comments:
Leave a comment. Thanks!